APA (7th ed.) Citation

ZT, Y., M, O., DM, C., M, A., L, S., MA, E., . . . MB, S. (2025). 2-Hydroxybenzylamine for Treatment of Atrial Fibrillation: A First-in-Human Clinical Pilot Trial. Circulation. Arrhythmia and electrophysiology, 18(8), e013378. https://doi.org/10.1161/CIRCEP.124.013378

Chicago Style (17th ed.) Citation

ZT, Yoneda, et al. "2-Hydroxybenzylamine for Treatment of Atrial Fibrillation: A First-in-Human Clinical Pilot Trial." Circulation. Arrhythmia and Electrophysiology 18, no. 8 (2025): e013378. https://doi.org/10.1161/CIRCEP.124.013378.

MLA (9th ed.) Citation

ZT, Yoneda, et al. "2-Hydroxybenzylamine for Treatment of Atrial Fibrillation: A First-in-Human Clinical Pilot Trial." Circulation. Arrhythmia and Electrophysiology, vol. 18, no. 8, 2025, p. e013378, https://doi.org/10.1161/CIRCEP.124.013378.